Warm eyelid treatment for dry eye gets a boost?

NCT ID NCT07365735

Completed Symptom relief Sponsor: Sight Sciences, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested the TearCare MGX system, a device that applies heat to the eyelids, for treating dry eye caused by meibomian gland dysfunction. 21 adults with dry eye symptoms received the treatment, comparing a standard version with one that includes an extended warming hold. The goal was to see if the warming hold improves gland secretions and eye comfort.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: localized heat therapy device
What this could lead to: If successful, this could improve the treatment of evaporative dry eye by enhancing meibomian gland function.
What could go wrong: This is a small, early-stage trial with only 21 participants, so results may not apply to everyone. The device is already FDA-cleared, so the main question is whether the warming hold feature adds benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EVAPORATIVE DRY EYE DISEASE DUE TO MEIBOMIAN GLAND DYSFUNCTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

dry eye syndrome Meibomian Gland Dysfunction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MEIBOMIAN GLAND DYSFUNCTION (DISORDER)

Contacts and locations

Locations

Cleveland Eye Clinic

Brecksville, Ohio, 44141, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.